XIST knockdown caused significant suppression of glioma cell proliferation and chemoresistance, whereas miR-29c inhibition promoted glioma cell proliferation and chemoresistance; the effect of XIST knockdown on the indicated TMZ-resistant glioma cells could be partially reversed by miR-29c inhibition. The gene discussed is XIST; the disease is central nervous system cancer.